Literature DB >> 1428127

Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin.

W Pruzanski1, D W Wilmore, A Suffredini, G D Martich, A G Hoffman, J L Browning, E Stefanski, B Sternby, P Vadas.   

Abstract

Phospholipase A2 (PLA2) activity was measured in the serum of 23 individuals infused intravenously with endotoxin (EN) at a dose of 4 ng/kg body weight. A marked increase in PLA2 was noted 3 h after EN challenge (mean 828 +/- 513 units/ml), reached its maximum at 24 h after the challenge (mean 2667 +/- 2442 units/ml), and was still evident at 48 h (mean 763 +/- 366 units/ml). In contrast, TNF levels were maximal (mean 712 +/- 375 pg/ml) 90 min after the EN challenge and subsided to very low values (5 +/- 5 pg/ml) 5 h after the challenge. There was a positive correlation between the maximum response of TNF and that of PLA2 (r = 0.82, P < 0.01). Administration of ibuprofen or pentoxifylline did not alter the PLA2 response. EN challenge did not affect serum pancreatic PLA2 concentration or that of the lysosomal cationic enzyme, lysozyme. Neutralizing antibody against human recombinant (synovial type) PLA2 completely abolished PLA2 activity in the sera tested. We conclude that EN infusions cause marked intravascular release of nonpancreatic secretory PLA2 and that the magnitude of this response seems to be related to the prior generation of TNF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428127     DOI: 10.1007/bf00918980

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  52 in total

1.  Relevance of serum phospholipase A2 assays to the assessment of septic shock.

Authors:  M F Heath; D Tighe; R Moss; E D Bennett
Journal:  Crit Care Med       Date:  1990-07       Impact factor: 7.598

2.  Release of phospholipase A2 activity from rat vascular smooth muscle cells mediated by cAMP.

Authors:  J Pfeilschifter; W Pignat; F Märki; I Wiesenberg
Journal:  Eur J Biochem       Date:  1989-04-15

3.  Effects of recombinant human interleukin-1 beta on rabbit articular chondrocytes. Stimulation of prostanoid release and inhibition of cell growth.

Authors:  J E Chin; Y A Lin
Journal:  Arthritis Rheum       Date:  1988-10

4.  Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?

Authors:  P Vadas; W Pruzanski; E Stefanski
Journal:  Agents Actions       Date:  1988-07

5.  Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock.

Authors:  P Vadas; J B Hay
Journal:  Can J Physiol Pharmacol       Date:  1983-06       Impact factor: 2.273

6.  Structure and properties of a human non-pancreatic phospholipase A2.

Authors:  R M Kramer; C Hession; B Johansen; G Hayes; P McGray; E P Chow; R Tizard; R B Pepinsky
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

7.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

8.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05

9.  Cytokine appearance in human endotoxemia and primate bacteremia.

Authors:  D G Hesse; K J Tracey; Y Fong; K R Manogue; M A Palladino; A Cerami; G T Shires; S F Lowry
Journal:  Surg Gynecol Obstet       Date:  1988-02

10.  Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.

Authors:  G D Martich; R L Danner; M Ceska; A F Suffredini
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  10 in total

1.  Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.

Authors:  B Guidet; O Piot; J Masliah; V Barakett; E Maury; G Bereziat; G Offenstadt
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

2.  Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection.

Authors:  V J Laine; D S Grass; T J Nevalainen
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

3.  Secretion of phospholipase A2 induced by interactions of human platelets with monocytes.

Authors:  S Sipka; T Farkas; P Gergely; L Bali; J Laczko; S Szabados; I Csipo; M Koltai; G Szegedi
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

4.  Complement activation in relation to capillary leakage in children with septic shock and purpura.

Authors:  J A Hazelzet; R de Groot; G van Mierlo; K F Joosten; E van der Voort; A Eerenberg; M H Suur; W C Hop; C E Hack
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  Are events after endotoxemia related to circulating phospholipase A2?

Authors:  A A Santos; J L Browning; M R Scheltinga; E A Lynch; E F Brown; P Lawton; E Chambers; I Dougas; C D Benjamin; C A Dinarello
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

6.  Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.

Authors:  E C Landucci; E Antunes; J L Donato; R Faro; S Hyslop; S Marangoni; B Oliveira; G Cirino; G de Nucci
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

7.  Phospholipase A(2) activates hemostasis.

Authors:  Thomas W Stief
Journal:  Drug Target Insights       Date:  2007-03-22

8.  The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation.

Authors:  Etienne Doré; Charles Joly-Beauparlant; Satoshi Morozumi; Alban Mathieu; Tania Lévesque; Isabelle Allaeys; Anne-Claire Duchez; Nathalie Cloutier; Mickaël Leclercq; Antoine Bodein; Christine Payré; Cyril Martin; Agnes Petit-Paitel; Michael H Gelb; Manu Rangachari; Makoto Murakami; Laetitia Davidovic; Nicolas Flamand; Makoto Arita; Gérard Lambeau; Arnaud Droit; Eric Boilard
Journal:  JCI Insight       Date:  2022-01-25

9.  Sequential release of TNFalpha and phospholipase A(2) in a rat model of LPS-induced pleurisy.

Authors:  C Cicala; M Bucci; F D Acquisto; L Parente; G Cirino
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

10.  Lipidomics in Major Depressive Disorder.

Authors:  Andreas Walther; Carlo Vittorio Cannistraci; Kai Simons; Claudio Durán; Mathias J Gerl; Susanne Wehrli; Clemens Kirschbaum
Journal:  Front Psychiatry       Date:  2018-10-15       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.